Statistics for BioNTech SE (id:7128 BNTX)

Valuation metrics

Market cap

25.49B

Enterprise value

9.58B

Trailing P/E (ttm)

160.80

Forward P/E

-27.26

PEG ratio

-27.26

Price/Sales (ttm)

8.38

Price/Book (mrq)

1.33

Enterprise Value/Revenue

2.97

Enterprise Value/EBITDA

-32.87

Overview

Shares outstanding

239.74M

Float

91.56M

Shares short

2.41M

% Held by insiders

0.62%

% Held by institutions

0.19%

Average volume (10 days)

873.96K

Average volume (90 days)

Price summary

52-Week low

76.53

52-Week high

131.49

52-Week change

3.24%

Beta

0.26

50-Day moving average

112.26

200-Day moving average

95.34

Dividends and splits

Forward annual dividend rate

8.44

Forward annual dividend yield

0.08

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

June 17th, 2022

Ex-dividend date

June 02th, 2022

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-15.36%

Operating margin

1.68%

Operational effectiveness

Return on assets

-1.24%

Return on equity

-2.40%

Income statement

Revenue (ttm)

12.62

Revenue per share (ttm)

12.62

Quarterly revenue growth (yoy)

0.23

Gross profit (ttm)

3.22B

EBITDA

1.16B

Net income to common (ttm)

-495,880,483.00

Diluted EPS (ttm)

-2.08

Quarterly earnings growth (yoy)

23.40%

Balance sheet

Total cash (mrq)

17.75B

Total cash per share (mrq)

69.70

Total debt (mrq)

258.83M

Total Debt/Equity (mrq)

1.28

Current ratio (mrq)

732.90%

Book value per share (mrq)

79.73

Cash flow

Cash flow statement

1.62B

Levered free cash flow (LFCF)

1.49B